New research from the University of Geneva suggests that pancreatic beta cells may function more effectively in isolation, potentially reshaping our understanding of diabetes treatment.
UCSF researchers have developed a novel method to target GTPases, a family of enzymes linked to various diseases including cancer and Parkinson’s, potentially opening new avenues for drug development.
A new study highlights the potential of microbiome-based biomarkers whilst emphasising the need for validated analytical methods and international standards.
ETH Zurich researchers have developed a method to synthesise and test billions of new chemical compounds in weeks, potentially accelerating drug development and expanding the range of treatable conditions.
Researchers at Karolinska Institutet have uncovered key neural processes behind morphine’s analgesic effects, potentially paving the way for safer pain management strategies.
Vapourtec, a leading manufacturer of flow chemistry instruments, has launched the Peptide-ExplorerLT, a new system designed for chemists exploring and optimising linear peptide synthesis. This compact device aims to make Fast Flow Solid Phase Peptide Synthesis (FF-SPPS) more accessible to researchers.
Bio-Rad Laboratories has unveiled its latest offering in quality control products for clinical laboratories: the Specialty Immunoassay Plus (SPIA Plus). This new line of controls is designed to enhance precision in specialty immunoassay testing procedures.
Uniqsis, a specialist in mesoscale continuous flow chemistry systems, has unveiled a novel Tube-in-plate (TIP) reactor designed to address the challenges faced in synthetic chemistry experiments requiring efficient heat transfer. This new development offers a cost-effective alternative to traditional glass static mixer (GSM) reactor blocks, particularly for applications where static mixing is not a primary […]
Newcastle-based Newcells Biotech has unveiled a state-of-the-art imaging suite, strengthening its capabilities in pre-clinical drug development. The company, known for its in vitro models and bespoke assay services, aims to improve the prediction of in vivo human outcomes with this latest investment.
Vapourtec, a leading manufacturer of laboratory-scale flow chemistry instruments, has significantly upgraded its E-Series flow chemistry system with the introduction of optional user interface software. This development promises to expand the scope of research possibilities for chemists working in drug discovery and synthesis.
September 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.